Although the prognostic impact of CTNNB1 mutations in low-grade early-stage endometrial carcinoma has already been described [9,10], the biological mechanisms underlying the aggressive behavior of these tumors remain incompletely understood. Here, CTNNB1 is linked to endometrial carcinoma.